Carbohydrate Antigen 125 Serial Measurements after an Admission for Acute Heart Failure and Risk of Early Readmission;Mediciones seriadas de antígeno carbohidrato 125 tras un ingreso por insuficiencia cardiaca aguda y riesgo de reingreso precoz

Medicina Clinica

Volumn 139, Issue 11, 2012, Pages 479-486

  Miñana Escrivá, Gema ^a   Núñez, Julio ^a   Sanchis, Juan ^a   Bodi, Vicent ^a   Núñez, Eduardo ^a   Chorro, Francisco J ^a   Llàcer, Angel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Carbohydrate antigen; Heart failure; Readmission; Serial measurements

Indexed keywords

CA 125 ANTIGEN;

ACCURACY; ACUTE HEART FAILURE; ARTICLE; CARDIAC PATIENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; FOLLOW UP; HAZARD RATIO; HEART DEATH; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CA-125 ANTIGEN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PATIENT READMISSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT;

EID: 84867332774     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.05.029     Document Type: Article

References (39)

1. S.D. Solomon, J. Dobson, S. Pocock, H. Skali, J.J. McMurray, and C.B. Granger Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure Circulation 116 2007 1482 1487
2. S. Stewart, A. Jenkins, S. Buchan, A. McGuire, S. Capewell, and J.J. McMurray The current cost of heart failure to the National Health Service in the UK Eur J Heart Fail 4 2002 361 371
3. H.M. Krumholz, E.M. Parent, N. Tu, V. Vaccarino, Y. Wang, and M.J. Radford Readmission after hospitalization for congestive heart failure among Medicare beneficiaries Arch Intern Med 57 1997 99 104
4. J. Núñez, E. Núñez, L. Consuegra, J. Sanchis, V. Bodí, and A. Martínez-Brotons Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart 93 2007 716 721
5. J. Núñez, J. Sanchis, V. Bodí, G.C. Fonarow, E. Núñez, and V. Bertomeu-González Improvement in risk stratification with the combination of the tumor marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure Eur Heart J 31 2010 1752 1763
6. E. Varol, M. Ozaydin, A. Dogan, and F. Kosar Tumour marker levels in patients with chronic heart failure Eur J Heart Fail 7 2005 840 843
7. H.M. Turk, H. Pekdemir, S. Buyukberber, A. Sevinc, C. Camci, and R. Kocabas Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid Tumour Biol 24 2003 172 175
8. O. Turgut, I. Tandogan, M.B. Yilmaz, I. Gul, and A. Gurlek CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival Int J Cardiol 145 2009 71
9. F. Kosar, Y. Aksoy, G. Ozguntekin, I. Ozerol, and E. Varol Relationship between cytokines and tumour markers in patients with chronic heart failure Eur J Heart Fail 8 2006 270 274
10. G. Miñana, J. Núñez, J. Sanchis, V. Bodí, E. Núñez, and A. Llàcer CA125 and immunoinflammatory activity in acute heart failure Int J Cardiol 145 2010 547 548
11. N.T. Kouris, I.D. Zacharos, D.D. Kontogianni, G.S. Goranitou, M.D. Sifaki, and H.E. Grassos The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters Eur J Heart Fail 7 2005 199 203
12. P. Faggiano, A. D'Aloia, L. Brentana, T. Bignotti, C. Fiorina, and E. Vizzardi Serum levels of different tumour markers in patients with chronic heart failure Eur J Heart Fail 7 2005 57 61
13. H. Nägele, M. Bahlo, R. Klapdor, D. Schaeperkoetter, and W. Rödiger CA 125 and its relation to cardiac function Am Heart J 137 1999 1044 1049
14. H. Nägele, M. Bahlo, R. Klapdor, and W. Rödiger Fluctuations of tumor markers in heart failure patients pre and post heart transplantation Anticancer Res 19 1999 2531 2534
15. H. Nägele, M. Bahlo, R. Klapdor, and W. Rödiger Tumor marker determination after orthotopic heart transplantation J Heart Lung Transplant 18 1999 957 962
16. A. D'Aloia, P. Faggiano, G. Aurigemma, L. Bontempi, G. Ruggeri, and M. Metra Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis J Am Coll Cardiol 41 2003 1805 1811
17. S. Monteiro, F. Franco, S. Costa, P. Monteiro, H. Vieira, and L. Coelho Prognostic value of CA125 in advanced heart failure patients Int J Cardiol 140 2010 115 118
18. O. Turgut, I. Tandogan, M.B. Yilmaz, I. Gul, and A. Gurlek CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival Int J Cardiol 145 2010 71
19. Z. Dibbs, J. Thornby, B.G. White, and D.L. Mann Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials J Am Coll Cardiol 33 1999 1935 1942
20. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
21. J.M. Bidart, F. Thuillier, C. Augereau, J. Chalas, A. Daver, and N. Jacob Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring Clin Chem 45 1999 1695 1707
22. Núñez J, Núñez E, Sanchis J, Bodí V, Fonarow GC, Miñana G, et al. CA125 and BNP serial measurements for risk stratification following an episode of acute heart failure. Int J Cardiol. En prensa 2011. doi:10.1016/j.ijcard.2011.02.001.
23. M. Gheorghiade, F. Follath, P. Ponikowski, J.H. Barsuk, J.E. Blair, J.G. Cleland European Society of Cardiology, European Society of Intensive Care Medicine Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine Eur J Heart Fail 12 2010 May 423 433
24. M.S. Nieminen, M. Böhm, M.R. Cowie, H. Drexler, G.S. Filippatos, G. Jondeau ESC Committe for Practice Guideline (CPG) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure Eur Heart J 26 2005 384 416
25. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson Task Force for Diagnosis, Treatment of Acute, Chronic Heart Failure 2008 of European Society of Cardiology ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
26. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
27. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
28. H.M. Krumholz, Y.T. Chen, Y. Wang, V. Vaccarino, M.J. Radford, and R.I. Horwitz Predictors of readmission among elderly survivors of admission with heart failure Am Heart J 139 2000 72 77
29. E.F. Philbin, G.W. Dec, P.L. Jenkins, and T.G. DiSalvo Socioeconomic status as an independent risk factor for hospital readmission for heart failure Am J Cardiol 87 2001 1367 1371
30. E.F. Philbin, and T.G. DiSalvo Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure Am J Cardiol 82 1998 76 81
31. E.F. Philbin, and T.G. DiSalvo Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data J Am Coll Cardiol 33 1999 1560 1566
32. S.S. Rathore, F.A. Masoudi, Y. Wang, J.P. Curtis, J.M. Foody, and E.P. Havranek Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project Am Heart J 152 2006 371 378
33. M.H. Chin, and L. Goldman Correlates of early hospital readmission or death in patients with congestive heart failure Am J Cardiol 79 1997 1640 1644
34. C.M. O'Connor, A.B. Miller, J.E. Blair, M.A. Konstam, P. Wedge, M.C. Bahit Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program Am Heart J 159 2010 841 849
35. J.S. Ross, G.K. Mulvey, B. Stauffer, V. Patlolla, S.M. Bernheim, and P.S. Keenan Statistical models and patient predictors of readmission for heart failure: a systematic review Arch Intern Med 168 2008 1371 1386
36. F. Rodríguez Artalejo, P. Guallar Castillón, J.R. Banegas Banegas, and J. Rey Calero Variación geográfica en las hospitalizaciones y la mortalidad por insuficiencia cardíaca congestiva en España, 1980-1993 Rev Esp Cardiol 53 2000 776 782
37. G. Cotter, M. Metra, O. Milo-Cotter, H.C. Dittrich, and M. Gheorghiade Fluid overload in acute heart failure - re-distribution and other mechanisms beyond fluid accumulation Eur J Heart Fail 10 2008 165 169
38. P.C. Colombo, and U.P. Jorde The active role of venous congestion in the pathophysiology of acute decompensated heart failure Rev Esp Cardiol 63 2010 5 8
39. C. Lucas, W. Johnson, M.A. Hamilton, G.C. Fonarow, M.A. Woo, and C.M. Flavell Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure Am Heart J 140 2000 840 847